Skip to content

Drug interactions

Lomitapide + Mitomycin

Severity: Minor

Lomitapide and Mitomycin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide inhibits P-glycoprotein and may increase concentrations of substrates such as mitomycin. Increased mitomycin toxicity is possible but not well documented.

What this interaction means in plain words

Lomitapide and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lomitapide belongs to Cardiovascular; Mitomycin belongs to Oncology.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by lomitapide may reduce mitomycin efflux.

What to do

Monitor blood counts and renal function and watch for mitomycin toxicity. Consider a mitomycin dose reduction if toxicity emerges.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomitapide and Mitomycin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomitapide with Mitomycin?

MediHelp rates the interaction as minor. Lomitapide and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lomitapide inhibits P-glycoprotein and may increase concentrations of substrates such as mitomycin. Increased mitomycin toxicity is possible but not well documented.

How serious is the interaction between Lomitapide and Mitomycin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and renal function and watch for mitomycin toxicity. Consider a mitomycin dose reduction if toxicity emerges.

What other medicines interact with Mitomycin?

MediHelp also lists interactions of Mitomycin with, for example, Bacitracin, Deferiprone, Dengue vaccine. The full list is on the Mitomycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in